Obese patients are a large segment of the U.S. population and should be included in medical countermeasure and drug development studies. There are presently no clear dosing guidelines for obese pediatric patients. The U.S. Food and Drug Administration (FDA) in collaboration with the University of Maryland Center of Excellence in Regulatory Science and Innovation (M-CERSI)
The FDA's Pulmonary-Allergy Drugs Advisory Committee Meeting will convene on 9 November 2022 to discuss the request for Emergency Use Authorization (EUA) for sabizabulin oral capsule, a tubulin polymerization inhibitor, submitted by Veru Inc., for the treatment of SARS-CoV-2 infection in moderate to severe COVID-19 infections at high risk of acute respiratory distress syndrome. Sabizabulin
The 70th IAEM Annual Conference & EMEX will be held 11-17 November 2022 in Savannah, Georgia. The program features more than 150 speakers providing plenaries and breakout sessions under the umbrella theme, “Emergency Management Unmuted.” In addition, All DHS/FEMA pre-/post-conference training courses, the IAEM Leadership Symposium, IAEM K-12 Workshop, and the Ascenttra Advanced Exercise Design
The FDA and Product Quality Research Institute (PQRI) will host a webcast workshop on the Regulatory Framework for Distributed and Point of Care Pharmaceutical Manufacturing on 14-16 November 2022. Future pharmaceutical manufacturing may occur not only in large manufacturing facilities; it may occur in smaller, more geographically distributed facilities or even at the point of
The Biomedical Advanced Research and Development Authority (BARDA) 2022 Industry Day virtual event will be held 15-16 November 2022. BARDA, a component of the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR), invites you to participate in the annual conference to learn about U.S. Government
The World Antimicrobial Awareness Week and U.S. Antibiotic Awareness Week take place 18-24 November 2022. Antimicrobial resistance (AMR) occurs when bacteria, viruses, fungi and parasites change over time and no longer respond to medicines, making infections harder to treat and increasing the risk of disease spread, severe illness and death. As a result of drug
The U.S. Food and Drug Administration FDA will host an Industry Day on 6 December 2022 to discuss a Broad Agency Announcement (BAA) for state of the art advancements in technology, materials, processes, methods, devices, and techniques in pharmaceutical regulatory science. FDA funds extramural research through an agency-wide Broad Agency Announcement (BAA) for research and
The Association of Healthcare Emergency Preparedness Professionals will convene for the 2023 AHEPP Annual Conference in Scottsdale, AZ from March 1 & 2, 2023 and pre-conference on 28 February. This event is dedicated to advancing emergency preparedness in healthcare facilities, and specifically focuses on providing the latest research, education, and connections. Example topics and sessions include: Command,
The Third International Summit on Human Genome Editing will be held March 6-8, 2023 in London, UK. The event is being organized as a collaborative activity of the U.S. National Academy of Sciences and the U.S. National Academy of Medicine, the U.K.’s Royal Society and Academy of Medical Sciences, and The World Academy of Sciences. It
